IRON MEXC RealStocks
Own real IRON shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 06:04:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Disc Medicine, Inc. (IRON) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $77.92, with a market capitalization of $3.49B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $40.00 to $99.50. This page covers its latest market performance, valuation, price trends and company information.
$3.49B | |
$76.52 | |
$79.60 | |
$75.07 | |
$76.57 | |
734.71K | |
943.96K | |
-- | |
$99.50 | |
$40.00 | |
-- | |
2026-09-30 |
Disc Medicine, Inc. (IRON) last closed at $77.92 as of 2026-11-19 00:31:00, up 1.87% ($1.43) from the previous close of $76.57.
During the latest regular trading session, IRON traded between $75.07 and $79.60, with a volume of 734.71K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Disc Medicine, Inc. (IRON) moved from $81.26 to $77.92, representing a decline of 4.11% ($3.34).
The stock traded between $75.07 and $87.51 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 912.25 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 63.7%
IRON is currently trading at $77.92, placing it 63.7% of the way from its 52-week low of $40.00 to its 52-week high of $99.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 173 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Disc Medicine, Inc. (IRON) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IRON, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between IRON shares and USD.
IRON Shares to USD
1.00 IRON shares = 77.918 USD
Calculations are estimates based on the latest available price and are for reference only.